No significant direct correlations between the T cell, Treg or IL-17+ cell frequencies and disease-free or disease-specific survival were found (Supplementary Table 2), while the effect of other factors that may contribute to prognosis (comorbidity, prior tumor occurrence and smoking status) remained similar to the effect in patients with HPV-positive tumors (data not shown). This evidence concerns the gene IL17A and neoplasm.